MDGL Insider Transactions — Page 8
1,874 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 701–800; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| FRIEDMAN PAUL A | Director | 2024-04-04 | Sale | 5,299.0 | $242.25 |
| FRIEDMAN PAUL A | Director | 2024-04-04 | Sale | 6,273.0 | $241.07 |
| Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Sale | 2,089.0 | $246.32 |
| Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Sale | 18,917.0 | $245.34 |
| Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Sale | 4,070.0 | $244.68 |
| Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Sale | 2,634.0 | $243.68 |
| Taub Rebecca | Pres., R&D, and CMO | 2024-04-03 | Sale | 135.0 | $242.0 |
| FRIEDMAN PAUL A | Director | 2024-04-03 | Sale | 1,821.0 | $246.31 |
| FRIEDMAN PAUL A | Director | 2024-04-03 | Sale | 18,806.0 | $245.34 |
| FRIEDMAN PAUL A | Director | 2024-04-03 | Sale | 4,301.0 | $244.58 |
| FRIEDMAN PAUL A | Director | 2024-04-03 | Sale | 2,294.0 | $243.64 |
| FRIEDMAN PAUL A | Director | 2024-04-03 | Sale | 185.0 | $242.0 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 7.0 | $249.05 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 193.0 | $248.49 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 100.0 | $246.88 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 567.0 | $246.2 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 2,080.0 | $244.97 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 7,048.0 | $244.27 |
| BATE KENNETH | Director | 2024-04-02 | Sale | 1,217.0 | $243.28 |
| Daly James M | Director | 2024-04-02 | Sale | 200.0 | $248.45 |
| Daly James M | Director | 2024-04-02 | Sale | 43.0 | $247.03 |
| Daly James M | Director | 2024-04-02 | Sale | 557.0 | $246.3 |
| Daly James M | Director | 2024-04-02 | Sale | 2,991.0 | $244.89 |
| Daly James M | Director | 2024-04-02 | Sale | 6,279.0 | $244.19 |
| Daly James M | Director | 2024-04-02 | Sale | 842.0 | $243.26 |
| Levy Richard S | Director | 2024-04-01 | Sale | 300.0 | $267.07 |
| Levy Richard S | Director | 2024-04-01 | Sale | 713.0 | $265.28 |
| Levy Richard S | Director | 2024-04-01 | Sale | 100.0 | $259.07 |
| Levy Richard S | Director | 2024-04-01 | Sale | 1,600.0 | $257.93 |
| Levy Richard S | Director | 2024-04-01 | Sale | 3,900.0 | $256.88 |
| Levy Richard S | Director | 2024-04-01 | Sale | 4,387.0 | $255.9 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 274.0 | $266.91 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 700.0 | $265.36 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 116.0 | $264.73 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 143.0 | $263.08 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 841.0 | $262.18 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 200.0 | $259.13 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 2,104.0 | $258.24 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 2,790.0 | $257.33 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 7,411.0 | $256.49 |
| BATE KENNETH | Director | 2024-04-01 | Sale | 6,698.0 | $255.62 |
| Daly James M | Director | 2024-04-01 | Sale | 274.0 | $266.91 |
| Daly James M | Director | 2024-04-01 | Sale | 500.0 | $265.49 |
| Daly James M | Director | 2024-04-01 | Sale | 351.0 | $264.89 |
| Daly James M | Director | 2024-04-01 | Sale | 178.0 | $263.31 |
| Daly James M | Director | 2024-04-01 | Sale | 800.0 | $262.01 |
| Daly James M | Director | 2024-04-01 | Sale | 200.0 | $259.11 |
| Daly James M | Director | 2024-04-01 | Sale | 1,460.0 | $258.28 |
| Daly James M | Director | 2024-04-01 | Sale | 3,604.0 | $257.3 |
| Daly James M | Director | 2024-04-01 | Sale | 7,401.0 | $256.5 |
| Daly James M | Director | 2024-04-01 | Sale | 6,809.0 | $255.64 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-15 | Sale | 1,000.0 | $241.0 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-15 | Sale | 1,000.0 | $236.0 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-14 | Sale | 1,000.0 | $232.0 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2023-12-14 | Sale | 1,000.0 | $233.0 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 3,960.0 | $229.86 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 3,960.0 | $229.86 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 3,960.0 | $229.86 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 3,960.0 | $229.86 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 3,960.0 | $229.86 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 3,960.0 | $229.86 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 316.0 | $229.86 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 316.0 | $229.86 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 316.0 | $229.86 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 316.0 | $229.86 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 316.0 | $229.86 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 316.0 | $229.86 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 2,204.0 | $228.79 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 2,204.0 | $228.79 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 2,204.0 | $228.79 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 2,204.0 | $228.79 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 2,204.0 | $228.79 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 2,204.0 | $228.79 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 176.0 | $228.79 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 176.0 | $228.79 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 176.0 | $228.79 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 176.0 | $228.79 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 176.0 | $228.79 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 176.0 | $228.79 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 11,602.0 | $227.86 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 11,602.0 | $227.86 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 11,602.0 | $227.86 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 11,602.0 | $227.86 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 11,602.0 | $227.86 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 11,602.0 | $227.86 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 925.0 | $227.86 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 925.0 | $227.86 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 925.0 | $227.86 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 925.0 | $227.86 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 925.0 | $227.86 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 925.0 | $227.86 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 1,343.0 | $226.97 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 1,343.0 | $226.97 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 1,343.0 | $226.97 |
| Baker Brothers Life Sciences LP | Director | 2023-12-14 | Purchase | 1,343.0 | $226.97 |
| 667, L.P. | Director | 2023-12-14 | Purchase | 1,343.0 | $226.97 |
| Baker Bros. Advisors (GP) LLC | Director | 2023-12-14 | Purchase | 1,343.0 | $226.97 |
| BAKER JULIAN | Director | 2023-12-14 | Purchase | 107.0 | $226.97 |
| BAKER FELIX | Director | 2023-12-14 | Purchase | 107.0 | $226.97 |
| BAKER BROS. ADVISORS LP | Director | 2023-12-14 | Purchase | 107.0 | $226.97 |